ASRS 2023: Insights on AVD-104, a sialic-acid coated nanoparticle therapeutic for geographic atrophy
August 11th 2023Carl Regillo, MD, FACS, FASRS, spoke with our team following the annual ASRS meeting in Seattle, Washington to share insights from his presentation titled, "Modulation of Macrophages and Complement Dysfunction in Non-exudative AMD utilizing novel, sialic-acid coated nanoparticles." Aviceda Therapeutics is unlocking the proteogenomic code of AMD to target proteins and pathways linked to macular degeneration.
Read More
ASRS 2023: ZETA-1 phase 2 trial efficacy results for APX3330 with David Lally, MD
August 9th 2023David Lally, MD, spoke with our team about the ZETA-1 phase 2 trial efficacy results for APX3330, a novel, oral ref-1 inhibitor for the treatment of diabetic retinopathy at the 2023 ASRS annual meeting.
Read More
ASRS 2023: Michael Singer, MD, provides details on the Starlight Study for Stargardt disease
August 6th 2023At the 2023 ASRS annual meeting in Seattle, Washington, Michael Singer, MD, spoke with our team about the Starlight Study, which is an optogenetic study looking at patients who had Stargardt disease.
Read More
The Modern Retina team caught up with one of our board members, Fernando Arevalo, MD, PhD, FACS, FASRS, who shared information on his presentation on the treatment of progressively symptomatic retinal detachments associated with retinoschisis cases at the 2023 ASRS annual meeting.
Read More
ASRS 2023: Dante Pieramici, MD, provides update on OPT-302, or sozinibercept,
August 1st 2023At the 2023 ASRS annual meeting, Dante Pieramici, MD, spoke with our team to share information on OPT-302, or sozinibercept, for the treatment of neovascular AMD and other retinal vascular diseases.
Read More
ASRS 2023: Insights in infrared video for vitreous opacities with Shawn Kavoussi, MD
July 31st 2023Shawn Kavoussi, MD, shared insights from his research on using infrared video for vitreous opacities and comparing postoperative reduction in vitreous opacity scores using infrared video with the Heidelberg spectralis unit.
Read More
ASRS 2023: Michael Ip, MD, shares perspective of the 2023 meeting in Seattle
July 30th 2023Michael Ip, MD, shared his perspective on the 2023 ASRS meeting in Seattle, Washington. He noted presentations and trends that are key at this event and why he thinks they are valuable topics to understand and review for retina specialists.
Read More